WASHINGTON, Sept 22 (Reuters) - Allergan Inc (AGN.N) will face public scrutiny later this year over its bid to market its stomach-squeezing Lap-Band product to more Americans who want the weight-loss procedure.
WASHINGTON, Sept 22 (Reuters) - Allergan Inc (AGN.N) will face public scrutiny later this year over its bid to market its stomach-squeezing Lap-Band product to more Americans who want the weight-loss procedure.
